{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "12419472", "DateCompleted": {"Year": "2003", "Month": "05", "Day": "30"}, "DateRevised": {"Year": "2019", "Month": "08", "Day": "26"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0891-5849", "JournalIssue": {"Volume": "33", "Issue": "10", "PubDate": {"Year": "2002", "Month": "Nov", "Day": "15"}}, "Title": "Free radical biology & medicine", "ISOAbbreviation": "Free Radic Biol Med"}, "ArticleTitle": "Ozone-induced increase in exhaled 8-isoprostane in healthy subjects is resistant to inhaled budesonide.", "Pagination": {"StartPage": "1403", "EndPage": "1408", "MedlinePgn": "1403-8"}, "Abstract": {"AbstractText": ["The aim of this study was to quantify lung oxidant stress after short-term ozone exposure as reflected by 8-isoprostane concentrations in exhaled breath condensate (EBC) and to investigate the effects of inhaled budesonide on this response. 8-Isoprostane is a prostaglandin-F(2 alpha) isomer that is formed in vivo by free radical-catalyzed peroxidation of arachidonic acid. EBC is a noninvasive method to collect airway secretions. We undertook a double-blind, randomized, placebo-controlled, crossover study with inhaled budesonide (800 microg) or placebo twice daily for 2 weeks prior to ozone exposure (400 parts per billion) for 2 h in nine healthy nonsmokers. Exhaled 8-isoprostane was measured by an enzyme immunoassay. 8-Isoprostane was increased 4 h after ozone exposure compared to pre-exposure values in both placebo (36.9 +/- 3.9 pg/ml, mean +/- SEM, vs. 16.9 +/- 0.7 pg/ml; p <.001) and budesonide groups (33.4 +/- 2.6 pg/ml vs. 15.8 +/- 0.3 pg/ml; p <.001). Pretreatment with budesonide did not affect the increases in 8-isoprostane (mean differences 3.4 pg/ml, 95% CI -8.9 to 15.7, p =.54). Short-term ozone exposure causes acute increase in lung oxidative stress as reflected by exhaled 8-isoprostane. This increase is resistant to pretreatment with a high dose of inhaled budesonide."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, School of Medicine, Catholic University of the Sacred Heart, Rome, Italy. p.montuschi@ic.ac.uk"}], "Identifier": [], "LastName": "Montuschi", "ForeName": "Paolo", "Initials": "P"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Nightingale", "ForeName": "Julia A", "Initials": "JA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kharitonov", "ForeName": "Sergei A", "Initials": "SA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Barnes", "ForeName": "Peter J", "Initials": "PJ"}], "PublicationTypeList": ["Clinical Trial", "Journal Article", "Randomized Controlled Trial", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Free Radic Biol Med", "NlmUniqueID": "8709159", "ISSNLinking": "0891-5849"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "F2-Isoprostanes"}, {"RegistryNumber": "0", "NameOfSubstance": "Free Radicals"}, {"RegistryNumber": "0", "NameOfSubstance": "Placebos"}, {"RegistryNumber": "0", "NameOfSubstance": "Protein Isoforms"}, {"RegistryNumber": "0", "NameOfSubstance": "Vasoconstrictor Agents"}, {"RegistryNumber": "27415-26-5", "NameOfSubstance": "8-epi-prostaglandin F2alpha"}, {"RegistryNumber": "51333-22-3", "NameOfSubstance": "Budesonide"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "B7IN85G1HY", "NameOfSubstance": "Dinoprost"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Breath Tests"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Budesonide"}, {"QualifierName": [], "DescriptorName": "Cross-Over Studies"}, {"QualifierName": ["chemistry"], "DescriptorName": "Dinoprost"}, {"QualifierName": [], "DescriptorName": "Double-Blind Method"}, {"QualifierName": ["pharmacology"], "DescriptorName": "F2-Isoprostanes"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Free Radicals"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Immunoenzyme Techniques"}, {"QualifierName": ["physiology"], "DescriptorName": "Lung"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Placebos"}, {"QualifierName": [], "DescriptorName": "Protein Isoforms"}, {"QualifierName": [], "DescriptorName": "Random Allocation"}, {"QualifierName": [], "DescriptorName": "Smoking"}, {"QualifierName": ["metabolism"], "DescriptorName": "Sputum"}, {"QualifierName": [], "DescriptorName": "Time Factors"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Vasoconstrictor Agents"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2002", "Month": "11", "Day": "7", "Hour": "4", "Minute": "0"}, {"Year": "2003", "Month": "5", "Day": "31", "Hour": "5", "Minute": "0"}, {"Year": "2002", "Month": "11", "Day": "7", "Hour": "4", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["12419472", "10.1016/s0891-5849(02)01084-5", "S0891584902010845"]}}], "PubmedBookArticle": []}